Last reviewed · How we verify
NCT04361292
Ejaculatory Abstinence in IUI Cycles
NA trial testing INTRAUTERINE INSEMINATION in Infertility in 120 participants. Completed in 29 February 2020.
30 December 2019
Quick facts
| Lead sponsor | Pamukkale University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 120 |
| Start date | 1 January 2019 |
| Primary completion | 30 December 2019 |
| Estimated completion | 29 February 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- INTRAUTERINE INSEMINATION
Conditions studied
- Infertility — all drugs for Infertility →
- Spermatozoa — all drugs for Spermatozoa →
- Reproductive Disorder — all drugs for Reproductive Disorder →
Sponsor
Pamukkale University
Who can join
Adults 20 to 40, any sex, with Infertility or Spermatozoa. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Intrauterine insemination (IUI) combined with ovarian stimulation, has been an extensively used procedure for the treatment of patients with unexplained infertility. The aim of this study was to report the effect of ejaculatory abstinence on sperm DNA fragmentation and pregnancy rates in IUI cycles, as well as the correlation between the two.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of ejaculatory abstinence period on sperm DNA fragmentation and pregnancy outcome of intrauterine insemination cycles: A prospective randomized study.
Kabukçu C, Çil N, Çabuş Ü, Alataş E. · · 2021 · cited 15× · PMID 32902676 · DOI 10.1007/s00404-020-05783-0
Verify or expand the search:
- PubMed search for NCT04361292
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Pamukkale University trials
Trials by the same sponsor.
- NCT06667856 — Foot Core Exercise Training With Telerehabilitation · NA · suspended
- NCT07532499 — EMG-Triggered Electrical Stimulation After Median/Ulnar Nerve Repairs · NA · not yet recruiting
- NCT07473232 — Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoart · NA · not yet recruiting
- NCT07520084 — Predictors of Climate Change Health Literacy in Older Individuals · recruiting
- NCT07388316 — Functional Improvement and Fine Dexterity in Thumb Tendon Injuries · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04361292 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pamukkale University
- Last refreshed: 27 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04361292.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing